Accurate SERPINA1 analysis is fundamental for the early diagnosis of AATD, particularly in individuals presenting with unexplained lung disease, liver anomalies, or a family history of AATD. Identifying specific genotypes allows for personalized risk assessment and informs proactive clinical surveillance.
Creative Biolabs specializes in AAT protein analysis services. Our expert R&D team and state-of-the-art technical platforms are meticulously designed to fulfill your diverse SERPINA1 analysis needs, providing a powerful impetus to your critical research and diagnostic endeavors.
Introduction of SERPINA1
Alpha-1 antitrypsin (AAT), also recognized as SERPINA1, is a vital liver-synthesized protease inhibitor. It safeguards tissues, particularly the lungs, from destructive inflammatory enzymes like neutrophil elastase. Alpha-1 antitrypsin deficiency (AATD) is an inherited disorder caused by SERPINA1 gene mutations, with clinical severity influenced by specific gene variants. Notably, severe AATD increases the risk of both liver and non-liver cancers.
AAT: A Definitive Blood Biomarker for AATD
The most prevalent AATD form, the ZZ genotype, results in misshapen AAT proteins unable to effectively enter the bloodstream, leading to significantly reduced circulating AAT. This deficiency leaves lungs and other organs vulnerable, instigating chronic obstructive pulmonary disorders such as emphysema and bronchitis. Therefore, blood AAT concentration serves as an invaluable diagnostic biomarker for AATD.
As shown in Fig.1, there are four main kinds of AAT tests that can be used to assess the levels of the AAT protein in the blood and find inherited genetic variants that contribute to AATD. The technology platform and purpose of each detection method are different, and each method can be selected to fit the different needs of researchers.
Fig.1 Four different modes of analysis targeting AAT.
SERPINA1 Analysis Services at Creative Biolabs
Creative Biolabs delivers a premier and all-encompassing analysis service for AAT identification and quantification. Through continuous investment in pioneering research and the recruitment of exceptional scientific talent, we have established a suite of cutting-edge analytical platforms, encompassing immunoassay, DNA sequencing, and PCR technologies. This strategic integration enables us to cater to the diverse needs of our discerning clientele, ensuring that each assay combines established reliability with innovative advancements. Our methodologies are engineered to operate with lower sample volumes while simultaneously achieving superior sensitivity. These advanced platforms empower us to execute the following high-level SERPINA1 analysis services:
- AAT Blood Level Test
Precise quantitative measurement of circulating AAT protein.
- AAT Phenotype Test
Characterization of AAT protein variants through isoelectric focusing (IEF).
- AAT Genotyping
Targeted detection of common disease-associated SERPINA1 gene variants.
- AAT DNA Sequencing
Comprehensive full gene analysis to identify rare and novel mutations.
Service Workflow
Our SERPINA1 analysis services follow a meticulously structured workflow, designed for efficiency and precision, ensuring a seamless client experience:
01Initial Consultation
Our scientific experts will thoroughly discuss your specific research goals, experimental design, and sample characteristics to tailor the optimal analysis plan and address any preliminary questions you may have.
02Sample Provision
Clients provide the necessary starting materials, typically blood samples or buccal swabs, ensuring flexibility and convenience for various study types, from clinical diagnostics to large-scale population screening.
03Rigorous Sample Processing
We perform meticulous DNA extraction and stringent quality control, carefully preparing your samples to ensure their integrity and optimize them for subsequent, highly accurate molecular analysis.
04Advanced Platform Analysis
Samples undergo specialized testing using our state-of-the-art immunoassay, PCR, phenotyping, or DNA sequencing platforms, selected precisely based on your project's specific requirements, generating robust and reliable data.
05Comprehensive Results Delivery
You will receive detailed reports, complete raw data, and expert interpretations from our scientific team, providing actionable insights crucial for advancing your research and clinical decision-making endeavors.
Applications
Early Diagnosis and Risk Assessment
Guiding Therapeutic Strategies
The precise characterization of SERPINA1 variants directly influences therapeutic decisions. For patients with severe AATD, genotyping guides the consideration and tailoring of augmentation therapy, aiming to replenish deficient AAT levels and mitigate disease progression.
Genetic Counseling and Family Planning
Comprehensive SERPINA1 analysis provides critical information for genetic counseling. It enables the identification of carriers, facilitates informed family planning decisions, and allows for proactive screening of asymptomatic at-risk family members, potentially preventing advanced disease.
Investigating Disease Pathogenesis
Beyond AATD, SERPINA1 analysis is pivotal in research exploring its broader role in inflammation, autoimmune conditions, and cancer pathogenesis. Understanding variant-specific effects can uncover novel biomarkers and therapeutic targets for a range of complex diseases.
Service Highlights
- Unparalleled Accuracy: Our advanced DNA sequencing methodologies ensure unparalleled accuracy in identifying even rare SERPINA1 mutations, critical for definitive diagnoses and reliable research outcomes.
- Rapid Turnaround Times: Optimized workflows and efficient platforms ensure rapid turnaround times without compromising data quality. Timely results empower quicker research progression and clinical decisions.
- Customized Solutions: We offer flexible, tailored analysis plans, with experts collaborating closely to design bespoke solutions aligning with unique research objectives and budget considerations.
- Expert Scientific Support: Beyond data delivery, we provide dedicated scientific support. Our expert biologists and geneticists offer in-depth consultation and interpretation, ensuring you derive maximum value from your SERPINA1 analysis.
FAQs
-
Are there any specific pre-analytical requirements or patient preparations necessary before sample collection for SERPINA1 testing?
While most of our SERPINA1 analysis methods do not require extensive patient preparation, we recommend confirming any specific pre-analytical instructions, such as fasting or medication considerations, with our technical support team to ensure optimal sample quality.
-
How do you ensure the accuracy and reliability of its SERPINA1 analysis results?
We ensure the accuracy and reliability of SERPINA1 analysis results through rigorous quality control measures, validated protocols, the use of certified reference materials, and the expertise of our highly trained scientific personnel, maintaining the highest standards in all our testing.
-
Can you help interpret the clinical significance of complex or novel SERPINA1 gene variants identified through sequencing?
Yes, we provide expert interpretation for complex or novel SERPINA1 gene variants identified through sequencing, offering insights into their potential clinical significance in the context of known literature and patient phenotype to support informed decision-making.
-
Is SERPINA1 analysis available for both diagnostic purposes and large-scale research studies?
Absolutely, our SERPINA1 analysis services are designed to accommodate both individual diagnostic needs for clinical applications and high-throughput requirements for large-scale research studies, offering scalable solutions to meet diverse project demands efficiently.
-
What are the primary differences between AAT genotyping and AAT DNA sequencing services offered by Creative Biolabs?
AAT genotyping at Creative Biolabs targets common SERPINA1 variants using PCR-based methods, while AAT DNA sequencing provides a comprehensive analysis of the entire coding region of the SERPINA1 gene, capable of identifying rare and novel mutations.
-
Can I integrate your SERPINA1 analysis into my existing biomarker discovery pipeline?
Yes, our SERPINA1 analysis services are highly adaptable and can be seamlessly integrated into your existing biomarker discovery pipelines, providing crucial data points for validating targets, assessing disease progression, or evaluating therapeutic efficacy.
With excellent research teams and diverse technology platforms, Creative Biolabs is the best choice for your experimental research and drug development. We also provide customized analysis services for a variety of targets to meet your various research needs.
If you have any requirements for AAT protein analysis, please do not hesitate to contact us for more information.
For Research Use Only.
